- AAML1831: A Phase III Trial Comparing Standard Induction Therapy With CPX-351 in De Novo Pediatric AML: A Report From the Children's Oncology Group
2026/07/24 by Jessica A. Pollard, Todd A. Alonzo, Robert B. Gerbing +26 · 1 voice
Medicine · #Acute Lymphoblastic Leukemia research #Acute Myeloid Leukemia Research #Chemotherapy #Cumulative incidence #Cytarabine #Daunorubicin #Gemtuzumab ozogamicin #Hematopoietic Stem Cell Transplantation #Induction chemotherapy #Induction therapy #Interim #Interim analysis